Gentium S.p.A. today announced the Company's entry into an agreement with the National University Corporation Hamamatsu University School of Medicine , Fukushima Medical University and LINK Healthcare to support a clinical trial to evaluate the safety and pharmacokinetics of Defibrotide in healthy adults.
http://www.globenewswire.com/news-release/2012/12/05/509632/10014654/en/Gentium-To-Initiate-Clinical-Development-in-Japan-and-Expand-Named-Patient-Program-Access-to-Asia-and-Japan.html
http://www.globenewswire.com/news-release/2012/12/05/509632/10014654/en/Gentium-To-Initiate-Clinical-Development-in-Japan-and-Expand-Named-Patient-Program-Access-to-Asia-and-Japan.html
No comments:
Post a Comment